METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME Russian patent published in 2012 - IPC A61K31/122 A61K31/343 A61P3/10 A61P9/02 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely therapy and endocrinology, and concerns correction of lipoperoxidation accompanying hypolipidemic therapy of the patients with metabolic syndrome. That is ensured by the combined introduction of statins and coenzyme Q10 scheduled as follows: atorvastatin 20 mg a day in the evening, cudesan equivalent to the content of coenzyme Q10 30 mg a day in the morning daily for 8 weeks with a pause of 8 weeks and renewed introduction; the therapeutic course is 1 year.

EFFECT: such regiment and empirically prescribed drug doses provide intensified antioxidant protection and reduced free-radical lipid oxidation that in turn enables the prolonged introduction of statines that ensures a maximum hypolipidemic effect with no side effects of these preparations.

4 tbl, 2 ex